Geraniol degradation

pathways : Geraniol degradation

Fullview (zoomIn)

Related Pathways to "Geraniol degradation" content :

Related Genes to "Geraniol degradation" content :

EN | FR | US | DE | PL
NL | BE | UK | BG

Kits Elisa; taq POLYMERASE

Search in Google:

Share this page:

Quick order!
Enter catalog number :

Categories :

Gentaur; yes we can

Related products :

Catalog number	Product name	Quantity

624-15-7	Geraniol Geraniol	1g
G01010	Geraniol	250 G
16621-22	Geraniol CAS: 106-24-1	25ML
G01010	Geraniol	250 G
G01010	Geraniol	50 G
G01010	Geraniol	50 G
G01010	Geraniol	1000 G
16621-22	Geraniol	25ML
16621-22	Geraniol	25 ml
70131-51-0	1 ,6_Octadiene, 7_methyl_3_methylene_, geraniol fractions, distn.	1g
24034-73-9	Geranyl geraniol, all trans isomer (E,E,E)_Gernylgeraniol	1g
30-957	Autophagy is the major intracellular degradation system delivering cytoplasmic components to lysosomes, and it accounts for degradation of most long-lived proteins and some organelles. Cytoplasmic con	0.05 mg
30-956	Autophagy is the major intracellular degradation system delivering cytoplasmic components to lysosomes, and it accounts for degradation of most long-lived proteins and some organelles. Cytoplasmic con	0.05 mg
27-171	ERLIN2 plays an important role in the early steps of the endoplasmic reticulum-associated degradation (ERAD) pathway. It is involved in ITPR1 degradation by the ERAD pathway.	0.05 mg
31-050	MDM4 inhibits p53- and p73-mediated cell cycle arrest and apoptosis by binding its transcriptional activation domain. It inhibits degradation of MDM2. It can reverse MDM2-targeted degradation of p53 w	0.05 mg
31-051	MDM4 inhibits p53- and p73-mediated cell cycle arrest and apoptosis by binding its transcriptional activation domain. inhibits degradation of MDM2. It can reverse MDM2-targeted degradation of p53 whil	0.1 mg
SCH-4440-0826	NATIVE HUMAN FIBRIN DEGRADATION PRODUCT Y, Product Type Purified Protein, Specificity FIBRIN DEGRADATION PRODUCT Y, Target Species Human, Host N_A, Format Purified, Isotypes , Applications E, C	0.2 mg
SCH-4440-0626	NATIVE HUMAN FIBRIN DEGRADATION PRODUCT X, Product Type Purified Protein, Specificity FIBRIN DEGRADATION PRODUCT X, Target Species Human, Host N_A, Format Purified, Isotypes , Applications E, C	0.2 mg
4440-0826	NATIVE HUMAN FIBRIN DEGRADATION PRODUCT Y, Product Type Purified Protein, Specificity FIBRIN DEGRADATION PRODUCT Y, Target Species Human, Host N_A, Format Purified, Isotypes , Applications E, C	0.2 mg
4440-0626	NATIVE HUMAN FIBRIN DEGRADATION PRODUCT X, Product Type Purified Protein, Specificity FIBRIN DEGRADATION PRODUCT X, Target Species Human, Host N_A, Format Purified, Isotypes , Applications E, C	0.2 mg
SCH-4440-0456	NATIVE HUMAN FIBRIN DEGRADATION PRODUCT E, Product Type Purified Protein, Specificity FIBRIN DEGRADATION PRODUCT E, Target Species Human, Host N_A, Format Purified, Isotypes , Applications E, C	0.1 mg
4440-0456	NATIVE HUMAN FIBRIN DEGRADATION PRODUCT E, Product Type Purified Protein, Specificity FIBRIN DEGRADATION PRODUCT E, Target Species Human, Host N_A, Format Purified, Isotypes , Applications E, C	0.1 mg
4440-0276	NATIVE HUMAN FIBRIN DEGRADATION PRODUCT D_MONOMER, Product Type Purified Protein, Specificity FIBRIN DEGRADATION PRODUCT D_MONOMER, Target Species Human, Host N_A, Format Purified, Isotypes , Ap	0.2 mg
SCH-4440-0276	NATIVE HUMAN FIBRIN DEGRADATION PRODUCT D_MONOMER, Product Type Purified Protein, Specificity FIBRIN DEGRADATION PRODUCT D_MONOMER, Target Species Human, Host N_A, Format Purified, Isotypes , Ap	0.2 mg
BA222	Fibrin Degradation Product E	0.1 mg